PRE MARKET
Gift Nifty indicates a strong start for the broader index in India, with a gain of 219 points or 0.85 percent. The Nifty futures were trading around the 25,916.50 level.
The Dow Jones Industrial Average surged to close above the 50,000 mark for the first time on Friday, a historic moment for the blue-chip index that has outperformed its Wall Street peers this year as investors sought names beyond technology.
The index rose 1,206.95 points, or 2.47%, on Friday to finish at 50,115.67. The Dow is now up 4.3% for the year so far compared with a 1.3% gain for 2026 in the S&P 500 and a 0.9% decline for the year so far in the Nasdaq.
Asian markets leapt higher on Monday as a resounding win for Japanese Prime Minister Sanae Takaichi whetted appetites for more reflationary policies, while there was widespread investor relief at Wall Street’s last gasp rebound.
Japan’s Nikkei, Hong Kong’s Hang Seng, and the Taiwanese weighted index went up 4.67, 1.57, and 2.26 percent, respectively.
STOCKS IN NEWS
Reliance Industries
Reliance Consumer Products, the FMCG subsidiary of Reliance Industries, has acquired a majority stake in Australia’s popular “better-for-you” beverage company, Goodness Group Global (GGG). Under the strategic partnership, Reliance Consumer Products will help promote Goodness Group’s flagship healthy beverage brands, such as Nexba and PACE, a hydration brand co-created with Australian cricket captain Pat Cummins, across new markets, including India.
Ipca Laboratories
The company’s Active Pharmaceutical Ingredients (API) manufacturing facility at Tarapur (Palghar, Maharashtra) has received the Establishment Inspection Report, classifying the facility as Voluntary Action Indicated (VAI). This indicates that the facility is in a minimally acceptable state of compliance with current good manufacturing practices (CGMP). The US FDA inspected the said manufacturing facility from December 1 and December 5, 2025.
Aurobindo Pharma
The United States Food and Drug Administration (US FDA) inspected Unit III, a formulation manufacturing facility of Eugia Pharma Specialities, a wholly owned subsidiary of the company, at Pashamylaram, Telangana, from January 27 to February 6. The inspection concluded with 11 observations, which the company said are procedural in nature.
BEML
The Board has approved an estimated investment of approximately Rs 1,500 crore for a greenfield rail manufacturing facility, ‘BRAHMA’, at Umariya in Madhya Pradesh. The project is expected to be completed in a phased manner over five years.
Indian Renewable Energy Development Agency
The Board has approved raising funds of up to Rs 2,994 crore through a Qualified Institutions Placement (QIP) in one or more tranches, provided that the government’s shareholding, acting through the Ministry of New and Renewable Energy, does not dilute by more than 3.76 percent of the post-issue paid-up equity share capital of the company.
Source – Moneycontrol
